Formulation and stability screening of biotherapeutics

November 13, 2020

The stability of biopharmaceuticals is a complex mixture of parameters and plays a crucial role throughout the entire product lifecycle, from discovery through production and manufacturing. Making critical decisions that determine the success of a biopharmaceutical requires clear and precise results.

In this two-part webinar, Dr. Jie Wen (Sr. Scientist, Higher Order Structure, Biological Relevance and Characterization, Attribute Sciences Amgen) discusses the advantages of nanoDSF for thermal stability analysis with examples of applications such as developability and formulation studies as well as comparability studies of therapeutic proteins. Then, Dr. Charles Heffern (Product Manager, NanoTemper) presents how Prometheus empowers experienced organizations to improve their biologic discovery and development by using high-quality data to make better decisions.

Previous Article
nanoDSF as screening tool for enzyme libraries and biotechnology development
nanoDSF as screening tool for enzyme libraries and biotechnology development

Up next
The NanoTemper Story – Chapter 6: The Prometheus Panta
The NanoTemper Story – Chapter 6: The Prometheus Panta

Take a moment to consider what it would have been like to be a researcher in your field a hundred, fifty, o...

Ready to tackle your challenging stability characterizations?

Discover tools